- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metabolic Disease in United Kingdom
Total 147025 results
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
University of BathCompletedGlucose Metabolism DisordersUnited Kingdom
-
Imperial College LondonCompletedInsulin Resistance | Adiposity | Metabolomic Profile | microRNA ProfileUnited Kingdom
-
King's College LondonCompletedGlucose Metabolism Disorders | Appetitive BehaviorUnited Kingdom
-
King's College LondonUnknownGlucose Metabolism Disorders | Appetitive BehaviorUnited Kingdom
-
Dr. Schär AG / SPACompletedPhenylketonurias | Inborn Errors of Metabolism | Metabolic Disease | PKUUnited Kingdom
-
University of AberdeenActive, not recruitingGlucose Metabolism Disorders | Glucose IntoleranceUnited Kingdom
-
Hospira, now a wholly owned subsidiary of PfizerCompleted
-
Kemin Foods LCDSM Nutritional Products, Inc.Terminated
-
NorthSea Therapeutics B.V.CompletedDyslipidemiasUnited Kingdom
-
Kathryn BeardsallCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Dr. Schär AG / SPACompletedPhenylketonurias | Inborn Errors of Metabolism | Metabolic Disease | PKUUnited Kingdom
-
University of LeedsCompletedHyperglycaemiaUnited Kingdom
-
Vital Signs Solutions LtdRecruiting
-
Loughborough UniversityUniversity of BedfordshireCompletedPostprandial HyperglycemiaUnited Kingdom
-
Manchester University NHS Foundation TrustCompletedHypercholesterolemiaUnited Kingdom
-
The Leeds Teaching Hospitals NHS TrustUnknown
-
Liverpool John Moores UniversityDiabetes UKCompletedInsulin Resistance | Metabolic DiseaseUnited Kingdom
-
Quadram Institute BioscienceCompleted
-
Esperion Therapeutics, Inc.CompletedHyperlipidemiaUnited Kingdom
-
University of NottinghamUnknownInsulin ResistanceUnited Kingdom
-
Xention LtdCompleted
-
University of BathUniversity of Oxford; British Heart FoundationRecruiting
-
Vital Signs Solutions LtdCompleted
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaUnited Kingdom
-
Imperial College LondonMalaysia Palm Oil BoardCompletedLipidaemiaUnited Kingdom
-
St George's, University of LondonCompletedHyperglycemia | COPDUnited Kingdom
-
Kowa Research EuropeCompletedMetabolic SyndromeUnited Kingdom
-
Royal Devon and Exeter NHS Foundation TrustNovartis Pharmaceuticals; National Institute for Health Research, United KingdomCompletedInsulin Resistance | Microvascular DiseaseUnited Kingdom
-
Manchester University NHS Foundation TrustRecruiting
-
University of ReadingJordans Cereals (Biggleswade, UK)CompletedCardiovascular Disease | HypercholesterolemiaUnited Kingdom
-
Loughborough UniversityActive, not recruitingLipid Metabolism Disorders | Appetitive Behavior | Glucose Metabolism Disorders (Including Diabetes Mellitus)United Kingdom
-
Xention LtdCompleted
-
Keele UniversityBaxter Healthcare Corporation; National Institute for Health Research, United... and other collaboratorsCompletedGlucose Metabolism DisordersUnited Kingdom
-
University of RoehamptonCompletedHypercholesterolemiaUnited Kingdom
-
University of NottinghamBiotechnology and Biological Sciences Research CouncilCompleted
-
University of NottinghamCompletedInsulin Resistance | Age ProblemsUnited Kingdom
-
Novo Nordisk A/SCompletedHealthy Volunteers | HypercholesterolaemiaUnited Kingdom
-
University of ReadingMedical Research CouncilCompletedHypercholesterolemiaUnited Kingdom
-
Alnylam PharmaceuticalsThe Medicines CompanyCompletedHypercholesterolemiaUnited Kingdom
-
University of GlasgowSuspendedObesity | Metabolic Syndrome | Insulin ResistanceUnited Kingdom
-
University of LeicesterUniversity Hospitals, LeicesterCompleted
-
Nutricia UK LtdCompletedPKU | TyrosinemiasUnited Kingdom
-
University of CambridgeCambridge University Hospitals NHS Foundation Trust; European CommissionCompleted
-
Unilever R&DLeatherhead Food ResearchCompletedInsulin Resistance | SatietyUnited Kingdom
-
APR Applied Pharma Research s.a.RecruitingPhenylketonuriasUnited Kingdom
-
University of NottinghamFlorida Department of CitrusCompletedObesity | Insulin Resistance | DyslipidemiaUnited Kingdom
-
University of Central LancashireCompletedMetabolic SyndromeUnited Kingdom